Outcomes of Treatment in Patients with Elderly Postmenopausal Osteoporosis: Comparision of Oral and Parenteral Bisphosphonates

Objective: In this study, we aim to compare the efficacy of oral and parenteral bisphosphonates used in postmenopausal osteoporosis (OP)treatment. Materials and Methods: Between 2010 and 2015, patients older than 65 years who were diagnosed with postmenopausal OP and treated with oral or parenteral...

Full description

Bibliographic Details
Published in:	Türk Osteoporoz Dergisi
Main Authors:	Ahmet Aslan, Anıl Gülcü, Ahmet Özmeriç
Format:	Article
Language:	English
Published:	Turkish Society of Osteoporosis 2018-08-01
Subjects:	Postmenopausal osteoporosis treatment bisphosphonates
Online Access:	http://cms.galenos.com.tr/Uploads/Article_19912/TOD-24-53-En.pdf

Similar Items

Modern principles for the diagnosis and treatment of postmenopausal osteoporosis: a focus on bisphosphonates
by: I. B. Belyaeva, et al.
Published: (2020-08-01)

Efficacy and safety of denosumab and teriparatide versus oral bisphosphonates to treat postmenopausal osteoporosis: a systematic review and meta-analysis
by: Jia Yang, et al.
Published: (2024-09-01)

The efficacy and safety of denosumab in postmenopausal women with osteoporosis previously treated with bisphosphonates: A review
by: Yilin Zhu, et al.
Published: (2020-05-01)

Osteoporosis in women in menopause/postmenopause: what to do?
by: E. V. Kulchavenya, et al.
Published: (2021-01-01)

Bisphosphonate drug holidays: Can we recommend currently?
by: Vishal R Tandon, et al.
Published: (2014-01-01)

Effect of bisphosphonates on the risk of surgical site infection after anterior cervical discectomy and fusion (ACDF) in postmenopausal women with osteoporosis
by: Weilin Zhang, et al.
Published: (2026-04-01)

Bisphosphonates in the Management of Patients with Postmenopausal Osteoporosis; Back to the Future
by: Socrates E. Papapoulos, et al.
Published: (2025-07-01)

Long-term Treatment with Bisphosphonates and Their Side Effects in Postmenopausal Osteoporosis - Review
by: Merih Sarıdoğan, et al.
Published: (2010-12-01)

Efficacy of Bisphosphonates for the Treatment of Osteoporosis in Patients with Multiple Sclerosis
by: İlke Coşkun Benlidayı, et al.
Published: (2015-08-01)

The Effects of Bisphosphonates Used Continually or Intermittently on Fractures, Bone Mineral Density and Biochemical Parameters in Osteoporotic Patients - Original Investigation
by: Alev Çevikol, et al.
Published: (2010-04-01)

First Indian prospective randomized comparative study evaluating adherence and compliance of postmenopausal osteoporotic patients for daily alendronate, weekly risedronate and monthly ibandronate regimens of bisphosphonates
by: Vishal R Tandon, et al.
Published: (2014-01-01)

Bisphosphonate-induced atypical femoral shaft fracture: A case report
by: Ameer Mustafa Farrukh, et al.
Published: (2023-11-01)

Open, Prospective, Multi-Center, Two-Part Study of Patient Preference with Monthly Ibandronate Therapy in Women with Postmenopausal Osteoporosis Switched From Daily or Weekly Alendronate or Risendronate-BONCURE: Results of Turkish Sub-Study
by: Nurten Eskiyurt, et al.
Published: (2012-04-01)

Clinical outcomes and safety of combined calcitriol and bisphosphonates in treating postmenopausal osteoporosis: a retrospective cohort study
by: Xu Zhou, et al.
Published: (2025-04-01)

Back pain and spinal osteoporosis in clinical practice
by: N. V. Pizova, et al.
Published: (2019-12-01)

Search for genetic markers determining the efficiency of therapy with bisphosphonates in Russian women with postmenopausal osteoporosis: A pilot study
by: M. Yu. Krylov, et al.
Published: (2016-10-01)

Development of Osteonecrosis of the Jaw in a Patient Receiving Oral Bisphosphonates for Osteoporosis: A Case Report
by: Sina Esmaeilzadeh, et al.
Published: (2014-08-01)

The experience of the parenteral form of ibandrinic acid administration in different clinical situations of treatment of postmenopausal osteoporosis
by: L. A. Marchenkova, et al.
Published: (2021-06-01)

The Effects of Bisphosphonate Therapy on Upper Gastrointestinal Tract in Postmenopausal Women: A Preliminary Report
by: Zeliha Ünlü, et al.
Published: (2002-09-01)

Postmenopausal osteoporosis: pathophysiology, diagnosis, compliance with drug therapy. Original and generic drugs
by: V. P. Smetnik
Published: (2013-12-01)

Efficacy and safety of abaloparatide, denosumab, teriparatide, oral bisphosphonates, and intravenous bisphosphonates in the treatment of male osteoporosis: a systematic review and Bayesian network meta-analysis
by: Liangshi Chen, et al.
Published: (2025-04-01)

Clinical efficacy of denosumab, teriparatide, and oral bisphosphonates in the prevention of glucocorticoid-induced osteoporosis: a systematic review and meta-analysis
by: Chuanjian Yuan, et al.
Published: (2023-06-01)

Quality use of medicines: The postmenopausal woman with osteoporosis
by: Andy Gray, et al.
Published: (2003-05-01)

The use of bisphosphonates for the treatment and prevention of osteoporosis
by: O. A. Nikitinskaya, et al.
Published: (2022-08-01)

Improvement of Reduced Bone Mineral Density by Intermittent Cyclical Etidronate in Postmenopausal Asthmatic Patients Receiving Inhaled Corticosteroids
by: Hiroyasu Yamamoto, et al.
Published: (2005-01-01)

glucocorticoid osteoporosis; osteoporotic fracture; bisphosphonates; FRAX algorithm
by: Natalia Vladimirovna Toroptsova, et al.
Published: (2013-12-01)

Long-term consequences of osteoporosis therapy with bisphosphonates
by: Bárbara Gehrke, et al.
Published: (2023-11-01)

FARNESYL DIPHOSPHATE SYNTHASE (FDRS) AND GERANYLGERANYL DIPHOSPHATE SYNTHASE (GGSP1) GENE POLYMORPHISMS AND EFFICIENCY OF THERAPY WITH BISPHOSPHONATES IN RUSSIAN WOMEN WITH POSTMENOPAUSAL OSTEOPOROSIS: A PILOT STUDY
by: M. Yu. Krylov, et al.
Published: (2016-03-01)

Ubiquitylomes Analysis of the Whole blood in Postmenopausal Osteoporosis Patients and healthy Postmenopausal Women
by: Yi‐ran Yang, et al.
Published: (2019-12-01)

Irisin and Its Role in Postmenopausal Osteoporosis and Sarcopenia
by: Irene Falsetti, et al.
Published: (2024-04-01)

ACTIVE VITAMIN D METABOLITES IN THE TREATMENT OF POSTMENOPAUSAL OSTEOPOROSIS
by: O. V. Yakushevskaya
Published: (2017-12-01)

Efficacy of combination therapy of vitamin D and bisphosphonates in the treatment of postmenopausal osteoporosis: a systematic review and meta-analysis
by: Yuangui Yang, et al.
Published: (2024-11-01)

Prevalence of osteoporosis in postmenopausal women at Srinagarind Hospital, Khon Kaen University
by: Surangtip Surangtip, et al.
Published: (2010-03-01)

OSTEOPOROSIS: ASSESSMENT OF A RISK FOR RECURRENT LOW-TRAUMA FRACTURES IN POSTMENOPAUSAL WOMEN
by: O. V. Dobrovolskaya, et al.
Published: (2016-03-01)

Sarcopenia and Balance in Community-dwelling Women with Postmenopausal Osteoporosis
by: Bilinç Doğruöz Karatekin, et al.
Published: (2021-06-01)

Long-term use of Bonviva for the treatment of postmenopausal osteoporosis: new evidence
by: Olga Borisovna Yershova, et al.
Published: (2012-03-01)

Bisphosphonate-related osteonecrosis of the jaw: An insight
by: Shalini Kapoor, et al.
Published: (2013-01-01)

SCIMP: A Novel Targeted Gene for Postmenopausal Osteoporosis Progression
by: Xiaolei Sun, et al.
Published: (2023-05-01)

Comprarison of Risendronate and Raloxifene Treatment in Postmenopausal Osteoporosis - Original Investigation
by: Dilek Koç Yılmaz, et al.
Published: (2006-09-01)

Vertebral Fracture in Postmenopausal Women with and without Osteoporosis
by: Merih Özgen, et al.
Published: (2017-08-01)